Skip Navigation

Japanese Journal of Clinical Oncology 2005 35(2):94-96; doi:10.1093/jjco/hyi027
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Teng, H.-W.
Right arrow Articles by Chen, P.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teng, H.-W.
Right arrow Articles by Chen, P.-M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2005 Foundation for Promotion of Cancer Research

Case Report

Acute Pancreatitis During All-trans-retinoic Acid Treatment for Acute Promyelocytic Leukemia in a Patient Without Overt Hypertriglyceridemia

Hao-Wei Teng1,2, Li-Yuan Bai1,2, Ta-Chung Chao1,2, Wei-Shu Wang1,2 and Po-Min Chen1,2

1 Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital and 2 School of Medicine, National Yang-Ming University Taipei, Taiwan

For reprints and all correspondence: Po-Min Chen, Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, 201, Sec 2, Shih-Pai Road, Taipei 112, Taiwan. E-mail: pmchen{at}vghtpe.gov.tw

Received August 6, 2004; accepted September 29, 2004

All-trans-retinoic acid (ATRA) has been successfully used in the treatment of acute promyelocytic leukemia (APL). One of its adverse effects is acute pancreatitis. In the literature, a proposed cause of acute pancreatitis is hypertriglyceridemia. Here, we present the case of a 45-year-old male with APL, treated with ATRA combined with induction chemotherapy (cytarabine and idarubicin), who developed acute pancreatitis without overt hypertriglyceridemia. This finding suggests that hypertriglyceridemia might not be the sole contributing factor in the pathogenesis of ATRA-induced acute pancreatitis and that attention should be paid to the possibility that ATRA treatment causes acute pancreatitis in the absence of overt hypertriglyceridemia.

Key Words: acute promyelocytic leukemia • acute pancreatitis • all-trans-retinoic acid • hypertriglyceridemia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.